Daniel Neves Forte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Neves Forte has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
- João Gabriel Rosa Ramos
Clínica Florence - Salvador (BA), Brazil
4 shared publications - Agnaldo Soares Lima
Universidade Federal de Minas Gerais, Brazil
2 shared publications - Alessandro Landskron Diniz
A.C. Camargo Cancer Center, Brazil
2 shared publications - Alexandre Ferreira Oliveira
Brazilian Society of Oncological Surgery, University Hospital of the Federal University of Juiz de Fora, Head of the Oncology Service Juiz de Fora Minas Gerais Brazil
2 shared publications - Alexcia Camila Braun
A.C. Camargo Cancer Center, Brazil
2 shared publications - André Luís de Godoy
A.C. Camargo Cancer Center, Brazil
2 shared publications
Latest Publications
- Open Access
- 15 May 2026
- Published by FapUNIFESP (SciELO) in SciELO Preprints
- Vol. 39
PREVENTION, SURVEILLANCE, AND EARLY DETECTION OF HEPATOCELLULAR CARCINOMA – A BRAZILIAN MULTIDISCIPLINARY CONSENSUS
Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality and represents a growing public health challenge. Aims: To develop multidisciplinary evidence-based recommendations for the prevention and early detection of HCC. Methods: This consensus was coordinated by the Brazilian Society of Surgical Oncology, with the participation of 13 additional national societies. A steering committee defined the key clinical questions addressing prevention, surveillance, and early detection strategies. Recommendation statements were informed by a comprehensive, non-systematic review of the literature conducted using PubMed, Scopus, and the Cochrane Library. Results: Eighteen recommendations reached consensus, covering three main domains: (1) Primary prevention, including HBV vaccination, timely antiviral therapy for viral hepatitis, and lifestyle interventions for metabolic dysfunction. (2) Secondary prevention, outlining risk-based surveillance strategies for patients with advanced fibrosis or cirrhosis due to HBV, HCV, or MASLD. (3) Operational standards for surveillance, emphasizing ultrasound as the cornerstone of monitoring, the importance of structured reporting, management of small nodules, and the selective use of cross-sectional imaging. Conclusions: These multidisciplinary recommendations provide practical, adaptable guidance for HCC prevention, surveillance, and early detection. This guidance document aims to reduce the burden of HCC and support better clinical outcomes across diverse healthcare settings.
- 15 May 2026
- Published by FapUNIFESP (SciELO) in SciELO Preprints
- Vol. 39
Open AccessPREVENTION, SURVEILLANCE, AND EARLY DETECTION OF HEPATOCELLULAR CARCINOMA – A BRAZILIAN MULTIDISCIPLINARY CONSENSUS
Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality and represents a growing public health challenge. Aims: To develop multidisciplinary evidence-based recommendations for the prevention and early detection of HCC. Methods: This consensus was coordinated by the Brazilian Society of Surgical Oncology, with the participation of 13 additional national societies. A steering committee defined the key clinical questions addressing prevention, surveillance, and early detection strategies. Recommendation statements were informed by a comprehensive, non-systematic review of the literature conducted using PubMed, Scopus, and the Cochrane Library. Results: Eighteen recommendations reached consensus, covering three main domains: (1) Primary prevention, including HBV vaccination, timely antiviral therapy for viral hepatitis, and lifestyle interventions for metabolic dysfunction. (2) Secondary prevention, outlining risk-based surveillance strategies for patients with advanced fibrosis or cirrhosis due to HBV, HCV, or MASLD. (3) Operational standards for surveillance, emphasizing ultrasound as the cornerstone of monitoring, the importance of structured reporting, management of small nodules, and the selective use of cross-sectional imaging. Conclusions: These multidisciplinary recommendations provide practical, adaptable guidance for HCC prevention, surveillance, and early detection. This guidance document aims to reduce the burden of HCC and support better clinical outcomes across diverse healthcare settings.
- Open Access
- 27 April 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260301
Foundational principles for young intensivists to drive better outcomes: palliative care
As a young intensivist in the early 2000s, one of the authors was intensely focused on developing competencies to manage refractory shock, appropriately indicate dialysis, and perform other technically challenging procedures in the intensive care unit (ICU). At the time, this emphasis on the patient’s biological dimension led to a lived experience of inattentional blindness() […] As a young intensivist in the early 2000s, one of the authors was intensely focused on developing competencies to manage refractory shock, appropriately indicate dialysis, and perform other technically challenging procedures in the intensive care unit (ICU). At the time, this emphasis on the patient’s biological dimension led to a lived experience of inattentional blindness() […]
- 27 April 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260301
Open AccessFoundational principles for young intensivists to drive better outcomes: palliative care
As a young intensivist in the early 2000s, one of the authors was intensely focused on developing competencies to manage refractory shock, appropriately indicate dialysis, and perform other technically challenging procedures in the intensive care unit (ICU). At the time, this emphasis on the patient’s biological dimension led to a lived experience of inattentional blindness() […] As a young intensivist in the early 2000s, one of the authors was intensely focused on developing competencies to manage refractory shock, appropriately indicate dialysis, and perform other technically challenging procedures in the intensive care unit (ICU). At the time, this emphasis on the patient’s biological dimension led to a lived experience of inattentional blindness() […]
- Open Access
- 3 March 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260248
"One-way" clinical extubation: an alternative to tracheostomy or palliative extubation in patients receiving inappropriate mechanical ventilation?
An 82-year-old man with mild dementia was admitted with acute respiratory failure due to pneumonia. He was drowsy, hypotensive, and hypoxemic, requiring intubation and vasopressors. After 10 days, despite some clinical improvement, he remained intubated and neurologically impaired, with persistent hypoactive delirium. An 82-year-old man with mild dementia was admitted with acute respiratory failure due to pneumonia. He was drowsy, hypotensive, and hypoxemic, requiring intubation and vasopressors. After 10 days, despite some clinical improvement, he remained intubated and neurologically impaired, with persistent hypoactive delirium.
- 3 March 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260248
Open Access"One-way" clinical extubation: an alternative to tracheostomy or palliative extubation in patients receiving inappropriate mechanical ventilation?
An 82-year-old man with mild dementia was admitted with acute respiratory failure due to pneumonia. He was drowsy, hypotensive, and hypoxemic, requiring intubation and vasopressors. After 10 days, despite some clinical improvement, he remained intubated and neurologically impaired, with persistent hypoactive delirium. An 82-year-old man with mild dementia was admitted with acute respiratory failure due to pneumonia. He was drowsy, hypotensive, and hypoxemic, requiring intubation and vasopressors. After 10 days, despite some clinical improvement, he remained intubated and neurologically impaired, with persistent hypoactive delirium.
- Open Access
- 2 March 2026
- Published by Springer Nature in BMC Medical Ethics
- Vol. 27 (1)
The use of bioethical decision-making framework in the ICU of a public Brazilian hospital: a retrospective observational case series
Background: End-of-life decisions in critically ill patients lacking decisional capacity are ethically challenging. Addressing patient values—such as autonomy, dignity, and comfort—provides a person-centered basis for care, yet systematic value assessment remains inconsistent. Structured family conferences guided by a bioethical framework may help align treatment with patient preferences. This study describes how often life-sustaining treatment (LST) modifications in a Brazilian ICU were aligned with documented patient values. Methods: This retrospective observational case series reviewed electronic medical records of neurologically incapacitated adults admitted to a tertiary public ICU in São Paulo, Brazil (February 2022–August 2023). Eligible patients met predefined palliative care triggers. Data were extracted using standardized forms, focusing on demographics, clinical features, family conferences, decisions, and outcomes. Family conferences followed a structured bioethical framework and a communication model based on neurobiology to elicit patient values, which were categorized into predefined domains. Descriptive analyses were performed. The study followed STROBE guidelines, was ethics-approved with consent waiver, and did not influence clinical care. Results: Of 179 consecutive intensive care unit admissions screened, 40 patients met eligibility criteria. Most were male (65%) with a mean age of 63.5 years. Palliative care triggers included advanced age with severe comorbidities or multi-organ failure (32.5%) and cerebral ischemia (32.5%). Family conferences occurred in 57.5% of patients, typically within three days, involving sons or spouses. Patient values were documented in 50% of the cases. Of the total sample ( n = 40), the most frequently reported values were autonomy (37.5%) and avoidance of suffering (12.5%). Overall, 55% had LST modified—withholding (50%), withdrawal (7.5%)—and 42.5% of modifications were documented value-based, representing 73.9% of patients with family conferences. Outcomes included death with LST (25%), natural death after withholding/withdrawal (25%), discharge home (25%), hospice (20%), and ward transfer (5%). Conclusions: Structured family conferences supported by a bioethical and communication frameworks were associated with a high frequency of treatment decisions explicitly aligned with patient values. These findings demonstrate that systematic value-based decision-making is feasible in resource-limited public hospitals. Prospective multicenter studies are needed to confirm these results and evaluate their impact on quality of care and clinical outcomes.
- 2 March 2026
- Published by Springer Nature in BMC Medical Ethics
- Vol. 27 (1)
Open AccessThe use of bioethical decision-making framework in the ICU of a public Brazilian hospital: a retrospective observational case series
Background: End-of-life decisions in critically ill patients lacking decisional capacity are ethically challenging. Addressing patient values—such as autonomy, dignity, and comfort—provides a person-centered basis for care, yet systematic value assessment remains inconsistent. Structured family conferences guided by a bioethical framework may help align treatment with patient preferences. This study describes how often life-sustaining treatment (LST) modifications in a Brazilian ICU were aligned with documented patient values. Methods: This retrospective observational case series reviewed electronic medical records of neurologically incapacitated adults admitted to a tertiary public ICU in São Paulo, Brazil (February 2022–August 2023). Eligible patients met predefined palliative care triggers. Data were extracted using standardized forms, focusing on demographics, clinical features, family conferences, decisions, and outcomes. Family conferences followed a structured bioethical framework and a communication model based on neurobiology to elicit patient values, which were categorized into predefined domains. Descriptive analyses were performed. The study followed STROBE guidelines, was ethics-approved with consent waiver, and did not influence clinical care. Results: Of 179 consecutive intensive care unit admissions screened, 40 patients met eligibility criteria. Most were male (65%) with a mean age of 63.5 years. Palliative care triggers included advanced age with severe comorbidities or multi-organ failure (32.5%) and cerebral ischemia (32.5%). Family conferences occurred in 57.5% of patients, typically within three days, involving sons or spouses. Patient values were documented in 50% of the cases. Of the total sample ( n = 40), the most frequently reported values were autonomy (37.5%) and avoidance of suffering (12.5%). Overall, 55% had LST modified—withholding (50%), withdrawal (7.5%)—and 42.5% of modifications were documented value-based, representing 73.9% of patients with family conferences. Outcomes included death with LST (25%), natural death after withholding/withdrawal (25%), discharge home (25%), hospice (20%), and ward transfer (5%). Conclusions: Structured family conferences supported by a bioethical and communication frameworks were associated with a high frequency of treatment decisions explicitly aligned with patient values. These findings demonstrate that systematic value-based decision-making is feasible in resource-limited public hospitals. Prospective multicenter studies are needed to confirm these results and evaluate their impact on quality of care and clinical outcomes.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 39
Diagnosis, clinical assessment, and staging of hepatocellular carcinoma: a Brazilian multidisciplinary consensus
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with a rising incidence largely driven by chronic liver disease. Accurate diagnosis and appropriate clinical assessment at the time of presentation are essential, as therapeutic strategies and prognosis depend on tumor burden, liver function, portal hypertension, and patient performance status. Aim: To develop evidence-based, multidisciplinary recommendations to guide the diagnosis, clinical assessment, and staging of patients with HCC. Methods: This consensus was developed by 43 experts from surgical oncology, hepatology, clinical oncology, radiology, interventional radiology, pathology, liver transplantation, gastroenterology, radiation oncology, and palliative care, under the coordination of the Brazilian Society of Surgical Oncology and 13 collaborating national medical societies. A scientific steering committee predefined clinically relevant questions addressing radiological and histopathological diagnosis, clinical assessment, diagnostic work-up, management of patients at the time of HCC diagnosis, and staging. These questions were discussed and refined in multidisciplinary meetings and submitted to structured voting rounds. Results: The panel formulated 18 recommendations covering key aspects of HCC evaluation, including standardized application of Liver Imaging Reporting and Data System (LI-RADS®) for imaging-based diagnosis, management of indeterminate lesions, indications for biopsy, histopathological classification and reporting, immunohistochemical markers, assessment of hepatic function and portal hypertension, staging systems, diagnostic work-up, and the role of multidisciplinary care. The recommendations emphasize integration of imaging findings with liver-related factors and clinical context to support individualized decision-making. Conclusions: This multidisciplinary consensus provides practical, evidence-based recommendations for the diagnosis, clinical assessment, and staging of HCC. By promoting standardized diagnostic practices while reinforcing comprehensive patient evaluation and multidisciplinary management, this document aims to improve diagnostic accuracy, optimize treatment selection, and support safe care.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 39
Open AccessDiagnosis, clinical assessment, and staging of hepatocellular carcinoma: a Brazilian multidisciplinary consensus
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with a rising incidence largely driven by chronic liver disease. Accurate diagnosis and appropriate clinical assessment at the time of presentation are essential, as therapeutic strategies and prognosis depend on tumor burden, liver function, portal hypertension, and patient performance status. Aim: To develop evidence-based, multidisciplinary recommendations to guide the diagnosis, clinical assessment, and staging of patients with HCC. Methods: This consensus was developed by 43 experts from surgical oncology, hepatology, clinical oncology, radiology, interventional radiology, pathology, liver transplantation, gastroenterology, radiation oncology, and palliative care, under the coordination of the Brazilian Society of Surgical Oncology and 13 collaborating national medical societies. A scientific steering committee predefined clinically relevant questions addressing radiological and histopathological diagnosis, clinical assessment, diagnostic work-up, management of patients at the time of HCC diagnosis, and staging. These questions were discussed and refined in multidisciplinary meetings and submitted to structured voting rounds. Results: The panel formulated 18 recommendations covering key aspects of HCC evaluation, including standardized application of Liver Imaging Reporting and Data System (LI-RADS®) for imaging-based diagnosis, management of indeterminate lesions, indications for biopsy, histopathological classification and reporting, immunohistochemical markers, assessment of hepatic function and portal hypertension, staging systems, diagnostic work-up, and the role of multidisciplinary care. The recommendations emphasize integration of imaging findings with liver-related factors and clinical context to support individualized decision-making. Conclusions: This multidisciplinary consensus provides practical, evidence-based recommendations for the diagnosis, clinical assessment, and staging of HCC. By promoting standardized diagnostic practices while reinforcing comprehensive patient evaluation and multidisciplinary management, this document aims to improve diagnostic accuracy, optimize treatment selection, and support safe care.
- Open Access
- 6 September 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 24 (1) , 1-20
Mapping advance care planning and advance directives in Latin America
Background/aims: The extent to which low- and middle-income countries have implemented Advance Care Planning (ACP) and Advance Directives (AD) remains unclear. We aimed to map the current status of ACP/AD in Latin America. Methods: This cross-sectional, mixed-methods survey of ACP/AD in LA comprised interviews with 18 key informants from 18 out of 20 countries, most of whom were appointed by national Palliative Care Associations. Online interviews were conducted with each informant, covering a range of relevant topics from AD regulations to the use of ACP/AD in the context of end-of-life clinical decision making. We performed member checking and data triangulation to confirm our findings. Results: Only eight (44%) countries have some form of ACP/AD regulations. Most regulatory frameworks tend to adopt a legalistic pattern heavily influenced by the North American model. Despite that characteristic of AD regulations in LA, the leading strategy used by patients to avoid unwanted treatment at the end of life is through conversations with their families, whereas the least common strategy was consulting with a lawyer. In six (33%) countries, informants believed it was common for patients to grant their families permission to modify their previous choices regarding future treatments. The religiosity/spirituality of populations play an important role in the implementation of ACP in the region. Additionally, respecting patients’ preferences of care at the end of life appears to be tied more to aspects related to the characteristics of doctor-patient relationship, and the degree of integration of palliative care into the healthcare system than the existence or content of AD regulations. There was consensus that none of the countries provide sufficient education about ACP/AD to healthcare professionals. Conclusions: Our findings encourage rethinking ACP/AD in LA from a decolonial perspective, considering characteristics such as the preference for a relational model of autonomy in several countries and the importance of taking the religiosity/spirituality of individuals into account during ACP conversations. Our data also suggest that honoring patients’ preferences of care at the end of life entails integrating palliative care into health care systems, educating healthcare professionals and the population, and fostering longitudinal trusting relationships between those professionals, patients, and their families.
- 6 September 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 24 (1) , 1-20
Open AccessMapping advance care planning and advance directives in Latin America
Background/aims: The extent to which low- and middle-income countries have implemented Advance Care Planning (ACP) and Advance Directives (AD) remains unclear. We aimed to map the current status of ACP/AD in Latin America. Methods: This cross-sectional, mixed-methods survey of ACP/AD in LA comprised interviews with 18 key informants from 18 out of 20 countries, most of whom were appointed by national Palliative Care Associations. Online interviews were conducted with each informant, covering a range of relevant topics from AD regulations to the use of ACP/AD in the context of end-of-life clinical decision making. We performed member checking and data triangulation to confirm our findings. Results: Only eight (44%) countries have some form of ACP/AD regulations. Most regulatory frameworks tend to adopt a legalistic pattern heavily influenced by the North American model. Despite that characteristic of AD regulations in LA, the leading strategy used by patients to avoid unwanted treatment at the end of life is through conversations with their families, whereas the least common strategy was consulting with a lawyer. In six (33%) countries, informants believed it was common for patients to grant their families permission to modify their previous choices regarding future treatments. The religiosity/spirituality of populations play an important role in the implementation of ACP in the region. Additionally, respecting patients’ preferences of care at the end of life appears to be tied more to aspects related to the characteristics of doctor-patient relationship, and the degree of integration of palliative care into the healthcare system than the existence or content of AD regulations. There was consensus that none of the countries provide sufficient education about ACP/AD to healthcare professionals. Conclusions: Our findings encourage rethinking ACP/AD in LA from a decolonial perspective, considering characteristics such as the preference for a relational model of autonomy in several countries and the importance of taking the religiosity/spirituality of individuals into account during ACP conversations. Our data also suggest that honoring patients’ preferences of care at the end of life entails integrating palliative care into health care systems, educating healthcare professionals and the population, and fostering longitudinal trusting relationships between those professionals, patients, and their families.
- Open Access
- 9 February 2024
- Published by SAGE Publications in Palliative Medicine Reports
- Vol. 5 (1) , 86-93
The Hierarchy of Communication Needs: A Novel Communication Strategy for High Mistrust Settings Developed in a Brazilian COVID-ICU
Context: The COVID-19 pandemic presented unique challenges for health care systems. Overcrowded units, extreme illness severity, uncertain prognoses, and mistrust in providers resulted in a “pressure cooker” where traditional communication strategies were often insufficient. Objectives: Building on well-studied traditional communication interventions, neurobiology principles were used to create a novel communication strategy designed in the COVID-ICU to respond to the unique communication needs of patients within the context of a high mistrust setting. Methods: The hierarchy of communication needs recognizes three specific levels of communication that are essential within high-emotion and low-trust settings. The first level is to establish trust. The second level is to resonate with patients' emotions, helping to reduce arousal and improve empathy. The third level includes the more traditional content of disclosing prognostic information and shared decision-making. When facing communication challenges, clinicians are taught to move back a level and reattune to emotions and/or reestablish trust. Discussion: The COVID pandemic revealed the shortcomings of a primarily cognitive communication style. The hierarchy of communication needs emphasizes trust building, and emotional resonance as prerequisites of effective cognitive discussions, resulting in more effective clinician–patient communication that more fully incorporates cultural humility and better meets the needs of diverse patient populations. Additional research is needed to further develop this strategy and evaluate its impact on patient experience and outcomes.
- 9 February 2024
- Published by SAGE Publications in Palliative Medicine Reports
- Vol. 5 (1) , 86-93
Open AccessThe Hierarchy of Communication Needs: A Novel Communication Strategy for High Mistrust Settings Developed in a Brazilian COVID-ICU
Context: The COVID-19 pandemic presented unique challenges for health care systems. Overcrowded units, extreme illness severity, uncertain prognoses, and mistrust in providers resulted in a “pressure cooker” where traditional communication strategies were often insufficient. Objectives: Building on well-studied traditional communication interventions, neurobiology principles were used to create a novel communication strategy designed in the COVID-ICU to respond to the unique communication needs of patients within the context of a high mistrust setting. Methods: The hierarchy of communication needs recognizes three specific levels of communication that are essential within high-emotion and low-trust settings. The first level is to establish trust. The second level is to resonate with patients' emotions, helping to reduce arousal and improve empathy. The third level includes the more traditional content of disclosing prognostic information and shared decision-making. When facing communication challenges, clinicians are taught to move back a level and reattune to emotions and/or reestablish trust. Discussion: The COVID pandemic revealed the shortcomings of a primarily cognitive communication style. The hierarchy of communication needs emphasizes trust building, and emotional resonance as prerequisites of effective cognitive discussions, resulting in more effective clinician–patient communication that more fully incorporates cultural humility and better meets the needs of diverse patient populations. Additional research is needed to further develop this strategy and evaluate its impact on patient experience and outcomes.
- Open Access
- 12 August 2022
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 80 (5 suppl 1) , 328-335
Palliative care and neurology: a path to neuropalliativism
This article aims to expand the understanding of how it is possible to alleviate suffering and enable a dignified life trajectory for patients with progressive neurological diseases or with severe and permanent neurological impairment. The four most common disease trajectories described for people with chronic and progressive disease used to advance care planning, Brazilian normative ethical resolutions, evidence-based benefits of palliative care (PC), as well as particularities of PC in neurology, such as neurological symptom control, caring for existential and psychological suffering, care provider’s needs and particularities of pediatric neurologic PC are reviewed.
- 12 August 2022
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 80 (5 suppl 1) , 328-335
Open AccessPalliative care and neurology: a path to neuropalliativism
This article aims to expand the understanding of how it is possible to alleviate suffering and enable a dignified life trajectory for patients with progressive neurological diseases or with severe and permanent neurological impairment. The four most common disease trajectories described for people with chronic and progressive disease used to advance care planning, Brazilian normative ethical resolutions, evidence-based benefits of palliative care (PC), as well as particularities of PC in neurology, such as neurological symptom control, caring for existential and psychological suffering, care provider’s needs and particularities of pediatric neurologic PC are reviewed.